<DOC>
	<DOCNO>NCT01573741</DOCNO>
	<brief_summary>Primary Outcome Measures : Evaluate change neuroimaging biochemistry measure ketamine treatment . Secondary Outcome Measures : Evaluate effect ketamine depression symptom , manic symptom , global change psychiatric symptom , suicidal ideation .</brief_summary>
	<brief_title>Study Ketamine Antidepressant Major Depressive Disorder</brief_title>
	<detailed_description />
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<criteria>Male patient , age 18 65 year diagnosis MDD , currently depress current major depressive episode BD without psychotic feature recruit substudy . Current past history lack response one adequate antidepressant trial , operationally define use Antidepressant Treatment History Form ( ATHF ) ; fail adequate trial ECT would count adequate antidepressant trial . Subjects history DSMIV drug alcohol dependency abuse ( except caffeine nicotine dependence ) within precede 3 month . In addition , subject currently use oher antidepressant drug 2 week prior screen must negative alcohol drug urine test ( except prescribe benzodiazepine ) urine test screening . Serious , unstable illness include hepatic , renal , gastroenterologic , respiratory , cardiovascular ( include ischemic heart disease ) , endocrinologic , neurologic , immunologic , hematologic disease . Presence medical illness likely alter brain morphology and/or physiology ( e.g. , hypertension , diabetes ) even control medication . Clinically significant abnormal laboratory test . Subjects clinical hypothyroidism hyperthyroidism . Subjects one seizures without clear resolve etiology . Presence metallic ( ferromagnetic ) implant ( e.g , heart pacemaker , aneurysm clip ) . Subjects , investigator 's judgment , pose current serious suicidal homicidal risk , MADRS item 10 score</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>depressive ketamine antidepressant</keyword>
</DOC>